Nat Simons Bio Rad Laboratories, Inc. Transaction History

Meritage Group LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$268.26 - $339.48 $113,742 - $143,939	424 Added 56.08%	1,180 $322,000
Q1 2024 May 13, 2024	SELL	$304.11 - $351.99 $18,550 - $21,471	-61 Reduced 7.47%	756 $261,000
Q4 2023 Feb 12, 2024	BUY	$269.37 - $365.04 $220,075 - $298,237	817 New	817 $264,000
Q2 2023 Aug 11, 2023	BUY	$359.49 - $486.4 $270,695 - $366,259	753 New	753 $285,000
Q2 2022 Aug 12, 2022	SELL	$463.67 - $597.16 $150,229 - $193,479	-324 Reduced 40.86%	469 $232,000
Q1 2022 May 13, 2022	SELL	$524.57 - $735.42 $120,126 - $168,411	-229 Reduced 22.41%	793 $447,000
Q4 2021 Feb 11, 2022	BUY	$708.84 - $794.68 $401,203 - $449,788	566 Added 124.12%	1,022 $772,000
Q3 2021 Nov 15, 2021	SELL	$657.71 - $825.77 $272,949 - $342,694	-415 Reduced 47.65%	456 $340,000
Q2 2021 Aug 13, 2021	BUY	$576.64 - $649.04 $81,882 - $92,163	142 Added 19.48%	871 $561,000
Q1 2021 May 14, 2021	BUY	$547.01 - $662.35 $31,179 - $37,753	57 Added 8.48%	729 $416,000
Q4 2020 Feb 12, 2021	SELL	$510.68 - $643.45 $45,450 - $57,267	-89 Reduced 11.7%	672 $392,000
Q3 2020 Nov 13, 2020	BUY	$454.43 - $535.6 $345,821 - $407,591	761 New	761 $392,000

457

18.3M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $7.89B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Meritage Group LP, based on Form 13F filings with the SEC.

Stay updated on Meritage Group LP and Nat Simons with notifications on news.